Skip to main content

February 2026

CLRI Advertisement for PG Biotechnology, Biochemistry Professionals
M.Sc. Biotechnology / Bioscience / Biochemistry or B.Tech in Biotechnology 
Life Sciences, Biotechnology Jobs at IHBT
M.Sc. Botany / Biotechnology / Plant Tissue Culture / Life Sciences from a recognized University.
Research positions for Life Sciences candidates at ILBS
First Class Post Graduate Degree (Life Sciences), including the integrated PG degree (Life Sciences). OR Second Class Post Graduate Degree (Life Sciences) including the integrated PG degree (Life Sciences) with PhD (Life Sciences)
Sun Pharma Hiring Analytical Development Senior Executive
Analytical method validation raw data and report review for different techniques like LC-MS/GC-MS/ICP -MS/ICP OES-MS for all regulated markets, Characterization & GMP Batch analysis.
Sun Pharmaceutical Industries Hiring for Production Apprentice
Preference will be given to candidates who are Ready to relocate in Dewas and Ready to work in shifts. Good Communication Skills. Good Subject Knowledge
Interview for Analytical - Trace Pharma Testing Division at VIMTA
Should have experience in the operation and calibration of GCMSMS / LCMSMS. Method development and validation; Preparation of reports.
Quality and Operations Openings at USV Private Limited
Responsible for FG testing, stability studies and analytical validation. Handling in-process QA, line clearance and compliance monitoring
Eisai Pharmaceuticals Opens Roles in Multiple Department
Having good experience and exposure in Granulation (ACG, Glatt, GEA ), Coating (Preference to Enteric & Sugar Coating), and Compression (Kilian & Fette Machines), Packing (CVC Blister Packing & Blister Cartonator).
AstraZeneca’s All-Oral Calquence Combo Wins US FDA Approval

AstraZeneca announced that the U.S. Food and Drug Administration has approved its fixed-duration all-oral combination of Calquence® (acalabrutinib) with venetoclax for the first-line treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in adults. The approval marks the first time a Bruton’s tyrosine kinase (BTK) inhibitor-based regimen has been authorised in the U.S. as a time-limited, oral treatment option for newly diagnosed patients.

Sai Life Sciences Plans to Hire 700+ Professionals in FY27 Amid Growth Surge

Sai Life Sciences Limited has announced an ambitious recruitment drive to hire more than 700 scientific, technical and management professionals in the 2026–27 financial year as it scales up operations to meet growing global demand for drug discovery, development and manufacturing services.